Skip to main content
. 2010 Apr 5;28(13):2198–2206. doi: 10.1200/JCO.2009.26.7245

Fig 5.

Fig 5.

(A) Multigene signatures of chemosensitivity to doxorubicin and docetaxel demonstrate substantial agreement when applied prospectively to the replicate samples (A-R) breast cancer data set. Capital letters are patient designations. Gold solid circles, complete concordance; blue solid circles, discordant samples. (B) Under a multilevel classification of higher sensitivity to one agent or of double resistance, 13 of 18 patients show complete concordance.